SKI Market

A+| A| A-|

Indian Indices

Sensex

76,664.21 -999.79
( -1.29%)

Global Indices

Nasdaq

49,330.80 -180.24
(-0.36%)

Dow Jones

7,129.46 -29.44
(-0.41%)

Hang Seng

59,744.07 603.84
(1.02%)

Nikkei 225

10,387.94 -69.07
(-0.66%)

Forex

USD-INR

93.75 0.31
(0.34%)

EUR-INR

109.98 0.10
(0.09%)

GBP-INR

126.66 0.42
(0.33%)

JPY-INR

0.59 0.00
(0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Laurus Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540222

INE947Q01028

91.1058881

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LAURUSLABS

76.12

60939.01

EPS(TTM)

Face Value()

Div & Yield %

14.83

0.11

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	1011.58	594.95	449.22	329.78	344.85	370.44
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1011.58	594.95	449.22	329.78	344.85	370.44
Other Income	95.79	76.29	72.25	73.45	110.57	111.33
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	1107.37	671.24	521.47	403.23	455.42	481.77
EXPENDITURE :
Raw Materials	0.00	0.00	0.00	0.00	0.00	0.00
Power & Fuel Cost	4.93	3.95	3.37	2.35	2.29	3.15
Employee Cost	116.98	89.35	74.70	65.11	62.34	65.88
Other Manufacturing Expenses	190.46	110.72	194.76	1.52	1.70	2.58
Selling & Administrative Expenses	114.16	327.10	42.87	122.07	124.12	137.26
Miscellaneous Expenses	65.01	34.89	13.77	30.81	13.64	16.27
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	491.54	566.01	329.47	221.86	204.09	225.14
Operating Profit	615.83	105.23	192.00	181.37	251.33	256.63
Interest	0.17	0.23	0.18	0.26	0.31	0.20
Gross Profit	615.66	105.00	191.82	181.11	251.02	256.43
Depreciation	61.61	34.39	20.47	22.14	21.64	17.84
Profit Before Tax	554.05	70.61	171.35	158.97	229.38	238.59
Tax	125.22	8.34	51.65	39.86	45.26	32.85
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	14.05	10.31	-10.13	0.65	-3.70	-2.78
Reported Net Profit	414.78	51.96	129.83	118.46	187.82	208.52
Extraordinary Items	0.03	0.00	0.00	-16.73	40.87	55.05
Adjusted Net Profit	414.75	51.96	129.83	135.19	146.95	153.47
Adjustment below Net Profit	0.63	0.00	0.00	0.00	0.00	-19.45
P & L Balance brought forward	1158.75	1204.15	1163.06	1185.36	1150.54	1063.47
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	38.96	97.36	88.74	140.76	153.00	102.00
P & L Balance carried down	1535.20	1158.75	1204.15	1163.06	1185.36	1150.54
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	300.00	76.40	190.90	174.00	276.00	300.00
Dividend Per Share(Rs)	30.00	7.64	19.09	17.40	27.60	30.00
Earnings Per Share-Unit Curr	81.33	10.19	25.46	23.23	36.83	40.89
Earnings Per Share(Adj)-Unit Curr	16.27	2.04	5.09	4.65	7.37	8.18
Book Value-Unit Curr	377.94	303.34	312.88	304.96	309.87	303.24
Book Value(Adj)-Unit Curr	75.59	60.67	62.58	60.99	61.97	60.65

76,664.21 -999.79 ( -1.29%)

49,330.80 -180.24 (-0.36%)

7,129.46 -29.44 (-0.41%)

59,744.07 603.84 (1.02%)

10,387.94 -69.07 (-0.66%)

93.75 0.31 (0.34%)

109.98 0.10 (0.09%)

126.66 0.42 (0.33%)

0.59 0.00 (0.23%)